Alx Oncology Holdings's common stock is $140K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Alx Oncology Holdings (ALXO) currently reports a common stock of $140K as of June 2026. That compares with $54K in the prior-year period — up 155.6% year over year. Use the charts on this page to explore Alx Oncology Holdings's common stock history and peer comparisons.
Alx Oncology Holdings's common stock increased from $54K to $140K — a 155.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Alx Oncology Holdings reported $140K in common stock as of June 2026. That compares with $54K in the prior-year period — up 155.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $140K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alx Oncology Holdings, and consider following ALXO for alerts when major investors trade the stock.
Alx Oncology Holdings is classified in the Healthcare sector. On common stock, it currently shows $140K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALXO with unrelated industries.